Research Grants

Grant Name
Research Grants
Funder
International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Location
United States
Research Area
Blood Diseases
Bone Marrow
Cancer Biology
Cancer or Carcinogenesis
Epigenetics
Genomics
Immunology
Immunotherapy
Oncology
Tumor Immunology
Deadline
February 13, 2022
Grant Size
Upper $400,000USD Under the Roadmap Initiative, the IWMF will award Roadmap grants for 2-4 new research proposals each year, depending on funding availability. Each project shall be 2 years in length, at a cost of up to $200,000 per year per project.
Contact Info
Dr. Tom Hoffmann, IWMF Research Committee thoffmann@iwmf.com
Jennifer Silva, IWMF Operations Manager jsilva@iwmf.com
Website
Eligibility
Applicants must hold an M.D., Ph.D., or equivalent degree and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals, or laboratories. Applications may involve multiple such institutions, and the applicant should have an independent research or academic position. Applicants need not be U.S. citizens, and there are no restrictions on applicant age, race, gender, or creed. Applications from non-academic facilities, postdoctoral positions, and the National Institutes of Health are not eligible.
Description
The International Waldenstrom's Macroglobulinemia Foundation (IWMF) and the Leukemia & Lymphoma Society (LLS) are proud to announce the fourth IWMF-LLS STRATEGIC RESEARCH ROADMAP INITIATIVE - a Request for Proposals (RFP) to help further knowledge in four key domains of Waldenstrom's macroglobulinemia (WM) research:
- Genomics and Epigenomics
- Signaling
- Immunology/Immunotherapy
- Bone Marrow/Tumor MicroenvironmentThe IWMF supports research to understand the biology of WM, with the goals of improving quality of life for WM patients, discovering new treatments, and ultimately, finding a cure. IWMF funding for research has helped to provide insight into understanding the basic biology and genetics of WM. This research in turn has played a significant role in the development of treatments and treatment guidelines in current use, as well as potential new drugs still in the pipeline. Eligibility Applicants must hold an M.D., Ph.D., or equivalent degree and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals, or laboratories. Applications may involve multiple such institutions, and the applicant should have an independent research or academic position. Applicants need not be U.S. citizens, and there are no restrictions on applicant age, race, gender, or creed. Applications from non-academic facilities, postdoctoral positions, and the National Institutes of Health are not eligible.

Quick share


Add deadline to calendar

February 13, 2022

Related grants

Ted and Elaine Welp Enhanced Career Development Award - Enhanced Research and Clinical Training for Physicians in Inherited Orphan Retinal Degenerative Diseases
Blindness January 31, 2022 Upper $510,000USD Up to a total of $170,...
Extramural Award
Alzheimers Disease February 1, 2022 $250,000USD The Foundation will be award...
Emerging Scholar Award
Biomedical Research (Multidisciplinary) February 5, 2022 Upper $600,000CAD The current funding en...
PIDS-St. Jude Children's Research Hospital Fellowship Program in Basic and Translational Research
Infectious Diseases April 1, 2022 Upper $270,000USD Support for a total of...
Physician Training Awards in Cancer Prevention
Cancer or Carcinogenesis April 1, 2022 $300,000USD Awards are made for 4 years...
Research Grants
Cancer or Carcinogenesis May 11, 2022 Upper £220,000GBP The award duration is...
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
Medicine May 27, 2022 Up to 750,000 USD
Sofina Covid Solidarity Fund
COVID-19 June 30, 2022 €500,000EUR Selected projects will recei...
Translational Neural Devices (U44 Clinical Trial Optional)
Health February 20, 2024 $1,000,000
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): Targeted MNCH/FP/RH technical assistance to private providers
Medicine September 30, 2025 Up to 75,000,000 USD